Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (propiolactone inactivated) Completed Phase 3 Trials for Flu caused by Influenza Prevention

Indications	Status	Purpose	Phase
DBCOND0021701 (Flu caused by Influenza)	Completed	Prevention	3

clinicaltrials.gov Identifier	Title	Drugs
NCT01422512	Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects	Influenza A virus A/California/7/2009(H1N1)-like antigen (formaldehyde inactivated) (DB10802) Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (propiolactone inactivated) (DB14402) Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (propiolactone inactivated) (DB14470)